Join us for the SCB's spring 2017 stakeholder meeting


may 24, 2017
3:30pm - 5:00pm

holland & knight llp
Washington, d.c.

 

The Standards Coordinating Body for regenerative medicine will be holding its first stakeholder meeting for active working groups in the Cell-Based Drug Discovery, Cell Therapy, Gene Therapy, and Tissue Engineering Sectors on May 24, 2017 in Washington, D.C. The overall goal of these working groups is to advance current projects in each sector space, generate new project and partnership opportunities, and encourage collaboration across the SCB. We will also provide an update on SCB achievements and expansion activities that were accomplished in the first half of 2017. Please RSVP to Alexa Machikas (amachikas@regenmedscb.org) by May 19, 2017 to confirm your attendance. 

 

meeting agenda
 

I. Welcome & Overview

a. Strategy and Value Proposition

i. Legislative Mandate from the 21st Century Cures Act

b. Success: 1H17

c. Overview

  i. Operations

ii. Network Outreach & Education

iii. Website & Educational Resources

iv. Global Presence

II. Financial Update

a. Potential Funding Mechanisms

III. Project Proposal Process & Framework

IV. Sector Updates

a. Cell-Based Drug Discovery

b. Cell Therapy

c. Gene Therapy

d. Tissue Engineering

V. Outlook: Fall & Winter 2017 and Beyond

VI. Closure of the Meeting

 

Holland & Knight LLP
800 17th Street NW
Washington, D.C. 20006
 

 

For more information on the meeting or ways to get involved, please contact us